Ranbaxy Shifts Lipitor Generic Production From U.S. To New India Plant
This article was originally published in PharmAsia News
Executive Summary
Ranbaxy Laboratories has begun transferring U.S. production of its generic version of Pfizer’s Lipitor (atorvastatin) cholesterol drug back home to India at its newly approved production facility in Mohali.